Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Volanesorsen sodium

EU orphan designation number: EU/3/16/1711   
Active ingredient: Volanesorsen sodium
Indication: Treatment of familial partial lipodystrophy
Sponsor: Ionis USA Limited
Tower 42, level 30, International Finance Centre, 25 Old Broad Street, London EC2N 1HQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/07/2016 Orphan designation EMA/OD/082/16 (2016) 4697 of 14/07/2016